[PRESS RELEASE] – EDMONTON, Alberta, Jan. 10, 2025 – Aurora Cannabis Inc., the Canadian-based leading global medical cannabis company, announced the launch of an internship program at Aurora's leading EU-GMP facility in Leuna, Germany. In partnership with Erfurt University of Applied Sciences, students of the Horticultural Crop Production course will gain valuable hands-on experience on-site and deepen their understanding of medical cannabis cultivation. Aurora's investment in future industry leaders is one of the many ways Aurora is expanding the frontiers of global medical cannabis.
"We are thrilled to be giving these students the opportunity to collaborate with our leading experts in the global medical cannabis industry, providing them with unparalleled insights and skills," said Michael Simon, president of Aurora Europe (Interim). "We are committed to nurturing talent and fostering a collaborative environment, ensuring that our interns leave with an enriched understanding of the industry and a solid foundation for their professional journeys."
Aurora's domestic cannabis facility in Leuna, Saxony-Anhalt, is one of the few sites in Germany permitted to grow medical cannabis. The state-of-the-art indoor facility meets the highest standards of operational excellence, using innovative and sustainable cultivation methods, making it an ideal site for students to learn best practices.
The six-month internship program will focus on all phases of medical cannabis cultivation, including cloning, care, harvesting, packaging and cleaning. Students will also participate in special research and development projects.
Aurora's proven expertise in not only developing premium medical cannabis products but in cultivating great talent, both domestically and globally, has allowed the company to maintain its leadership position as the largest global medical cannabis company operating in nationally legal markets.
